Blood condition may predict worse outcomes after heart attack

NCT ID NCT07615023

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study investigates whether a condition called clonal hematopoiesis of indeterminate potential (CHIP), which is an age-related change in blood cells, is linked to more severe heart damage in people who have had a major heart attack (STEMI). Researchers will test blood samples and use heart MRI scans in 350 patients to see if those with CHIP have worse outcomes, such as larger areas of heart damage or complications. The goal is to better understand risk factors for poor recovery after a heart attack.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If this study finds a link, it could point toward new ways to identify heart attack patients at higher risk for complications and guide future treatments.
What could go wrong
This is an observational study, not a treatment trial. It will only show an association, not cause and effect. The results may not apply to all patients or lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of Innsbruck

    Innsbruck, Tyrol, 6020, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.